Related references
Note: Only part of the references are listed.POS-298 LESSONS FROM FOUR DECADES OF SYSTEMIC AMYLOIDOSIS WITH RENAL INVOLVEMENT
N. MARQUES et al.
Kidney International Reports (2022)
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
Andrew Staron et al.
BLOOD CANCER JOURNAL (2021)
Two types of systemic amyloidosis in a single patient
Riccardo Papa et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)
Epidemiologic and Survival Trends in Amyloidosis, 1987-2019
Sriram Ravichandran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Merrill D. Benson et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers
Tamer Rezk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Why does it take so long? The reasons behind tuberculosis treatment delay in Portugal
I Zao et al.
PULMONOLOGY (2019)
Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis
Tamer Rezk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
Taxiarchis V. Kourelis et al.
BLOOD (2017)
Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience
Masatoyo Ozawa et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Systemic amyloidosis: novel therapies and role of biomarkers
Mario Nuvolone et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Unrecognized Fibrinogen A α-Chain Amyloidosis: Results From Targeted Genetic Testing
Isabel Tavares et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
Giovanni Palladini et al.
BLOOD (2014)
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis
Samar M. Said et al.
KIDNEY INTERNATIONAL (2014)
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
Ashutosh D. Wechalekar et al.
BLOOD (2013)
Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases
Samar M. Said et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Decreasing incidence of AA amyloidosis in Spain
Nayara Panizo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases
Wen Tang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients
Stefan O. Schoenland et al.
BLOOD (2012)
CyBorD: stellar response rates in AL amyloidosis
Giampaolo Merlini
BLOOD (2012)
Transthyretin Amyloidosis and the Kidney
Luisa Lobato et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Outcome in Renal AL Amyloidosis After Chemotherapy
Jennifer H. Pinney et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prevalence and Origin of Amyloid in Kidney Biopsies
Hanna von Hutten et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney
Morie A. Gertz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Presentation and outcome of patients with systemic amyloidosis undergoing dialysis
Guillaume Bollee et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Natural history and outcome in systemic AA amyloidosis
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Renal involvement in systemic amyloidosis - an Italian retrospective study on epidemiological and clinical data at diagnosis
Franco Bergesio et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment
Takeshi Kuroda et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
MA Gertz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M:: presentation, survival and prognostic factors
L Lobato et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2004)
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.
HJ Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Presentation, survival and prognostic markers in AA amyloidosis
N Joss et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
Share Paper
